Overview

Comparison the Effects of Etomidate and Sevoflurane During Electroconvulsive Therapy

Status:
Completed
Trial end date:
2017-02-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of the study was to investigate the effects of etomidate or sevoflurane used in electroconvulsive therapy (ECT) on duration of seizure, hemodynamic response and recovery profiles.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Inonu University
Treatments:
Etomidate
Sevoflurane
Criteria
Inclusion Criteria:

- Study include 25 patients of American Society of Anesthesiologists (ASA) physical
status I-II aged between 18-60 years who schedule for ECT sessions under general
anesthesia

Exclusion Criteria:

- Pregnancy

- Cerebrovascular disease

- Epilepsy

- Unstable cardiovascular disease

- Chronic obstructive pulmonary disease; and

- Renal or hepatic failure